Clint Capital

Clint Capital maintains a public footprint that includes LinkedIn and Crunchbase profiles, but no public website and limited disclosure of thesis specifics, fund size, geographic focus, or healthcare orientation. For healthcare AI founders, this opacity should be treated as informative: there is no clear public evidence of healthcare specialization, and the fund is most credibly understood as a small private-capital vehicle whose investment behavior depends on the principals’ private relationships and the specific business situation. Plausible check size is $250K to $1M based on typical small-fund economics, but this is a guess in the absence of disclosure. Stage focus is most plausibly seed and pre-seed. Founders who should approach: those with a direct introduction to Clint Capital and a software-shaped healthcare business that can be evaluated using SaaS-style frameworks; founders who need flexible private capital to fill out a primary-led seed round and are not depending on Clint for healthcare domain expertise or follow-on muscle. Founders who should not approach: regulated medical devices, biotech, those seeking lead investors, and any team that needs deep healthcare-specialist diligence. The realistic entry path is warm introduction through their LinkedIn network or co-investors in their orbit. Cold outbound is unlikely to convert without context. Before investing time in a meeting, ask any potential referrer specifically about Clint’s typical check size, recent deals, and whether they have any healthcare track record. If those answers are thin, redeploy your fundraising calendar to investors with demonstrated mandate alignment and a clearer public footprint.